During retinal development, the decision to exit the cell cycle must be precisely coordinated with cell fate specification and differentiation to ensure that the correct proportion of each cell type is generated. The Rb family of proteins (Rb, p107 and p130) regulate cell cycle exit, cell fate specification, differentiation and survival during development. In the previous funding period, we focused on the unique and overlapping roles of the Rb family in regulating retinal progenitor cell proliferation during development in mice and humans. These studies moved the field forward and allowed us to develop some of the first knockout mouse models of retinoblastoma. We used these and other preclinical models of retinoblastoma to test new therapies and our research has directly impacted an ongoing clinical trial (RET-5) at St. Jude. In this grant proposal, we will extend our previous studies and focus on the role of the Rb family in neuronal cell fate specification and differentiation. Our preliminary data suggest that Rb regulates these two processes through distinct mechanisms. Specifically, we propose that Rb regulates rod photoreceptor cell fate specification by repressing aE2Fs on the Chx10 and Pax6 promoters and Rb regulates rod photoreceptor differentiation through rE2Fs and histone modification to activate the Nrl, Nr2e3 and Crx promoters. This is the first example of such complex regulation of neurogenesis by a tumor suppressor. In contrast to rod photoreceptors, horizontal neurons in the developing retina do not require the Rb family for cell fate specification, migration or differentiation. However, in the absence of the Rb family, mature horizontal cells re-enter the cell cycle and form metastatic retinoblastoma while maintaining their differentiated state. These data challenge the widely held belief in developmental biology that differentiation and proliferation are incompatible in neurons. More importantly they suggest that cells that rely upon Rb for their normal development such as rod photoreceptors are resistant to tumor formation following Rb family inactivation but cells that do not rely upon the Rb family for their normal development such as horizontal cells are more susceptible to tumorigenesis following Rb family gene inactivation. We will determine here if the role of the Rb family during normal development in different cell types directly influences their susceptibility to become tumorigenic.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY014867-10
Application #
8274753
Study Section
Biology and Diseases of the Posterior Eye Study Section (BDPE)
Program Officer
Greenwell, Thomas
Project Start
2003-09-30
Project End
2014-06-30
Budget Start
2012-07-01
Budget End
2014-06-30
Support Year
10
Fiscal Year
2012
Total Cost
$399,168
Indirect Cost
$161,568
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Lu, Charles; Zhang, Jinghui; Nagahawatte, Panduka et al. (2015) The genomic landscape of childhood and adolescent melanoma. J Invest Dermatol 135:816-23
Tirode, Franck; Surdez, Didier; Ma, Xiaotu et al. (2014) Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. Cancer Discov 4:1342-53
Benavente, Claudia A; Finkelstein, David; Johnson, Dianna A et al. (2014) Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression. Oncotarget 5:9594-608
McEvoy, Justina; Nagahawatte, Panduka; Finkelstein, David et al. (2014) RB1 gene inactivation by chromothripsis in human retinoblastoma. Oncotarget 5:438-50
Chen, Xiang; Bahrami, Armita; Pappo, Alberto et al. (2014) Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. Cell Rep 7:104-12
Benavente, Claudia A; McEvoy, Justina D; Finkelstein, David et al. (2013) Cross-species genomic and epigenomic landscape of retinoblastoma. Oncotarget 4:844-59
Cheung, Nai-Kong V; Dyer, Michael A (2013) Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nat Rev Cancer 13:397-411
Zhang, Jinghui; Benavente, Claudia A; McEvoy, Justina et al. (2012) A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature 481:329-34
Cheung, Nai-Kong V; Zhang, Jinghui; Lu, Charles et al. (2012) Association of age at diagnosis and genetic mutations in patients with neuroblastoma. JAMA 307:1062-71
Brennan, Rachel C; Federico, Sara; Bradley, Cori et al. (2011) Targeting the p53 pathway in retinoblastoma with subconjunctival Nutlin-3a. Cancer Res 71:4205-13

Showing the most recent 10 out of 21 publications